Investors are turning their attention to five key nuclear stocks as market activity surges, according to data from MarketBeat’s stock screener tool. These stocks are part...
On August 16, 2023, Citizens Jmp began coverage of Assembly Biosciences (NASDAQ: ASMB), assigning an “outperform” rating along with a target price of $38.00. This biopharmaceutical...